CHRNA9 Antibody PA5-46826 from Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

(1) Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancersMolecular Therapy - Nucleic AcidsSeptember 12, 2023You-Cheng Liao, Tzu-Chun Cheng, Shih-Hsin Tu, Jungshan Chang, Peixuan Guo, Li-Ching Chen, Yuan-Soon Hofor 30 min with 2% bovine serum albumin (BSA) at room temperature. Primary antibodies against CHRNA9 (PA5-46826, Thermo Fisher Scientific, IL, USA) were diluted 1:100 in PBS with 1% BSA and then incubated with the

(2) The α9 Nicotinic Acetylcholine Receptor Mediates Nicotine-Induced PD-L1 Expression and Regulates Melanoma Cell Proliferation and MigrationCancersDecember 11, 2019Nguyen HD, Liao YC, Ho YS, Chen LC, Chang HW, Cheng TC, Liu D, Lee WR, Shen SC, Wu CH, et al.with appropriate primary antibodies against α9-nAChR (Thermo Fisher Scientific, Rockford, IL, USA, #PA5-46826), PD-L1 (Genetex, Irvine, CA, USA, #GTX104763; Thermo Fisher Scientific, #14-5983-82; Santa Cruz Biotechnology,

(3) DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpointInternational journal of cancerFebruary 1, 2019Lee WH, Chen LC, Lee CJ, Huang CC, Ho YS, Yang PS, Ho CT, Chang HL, Lin IH, Chang HW, et al.

WB